Graft-vs-Host Disease
Data from Thymidine Kinase Suicide Gene Program Published
Published in Gene Therapy Weekly, December 28th, 2000
The article was authored by a team of scientists including David Klatzmann, MD, PhD, an Avax consultant, and covers preclinical studies conducted at Pierre et Marie Curie University, Groupe Hospitalier Pitie-Salpetriere, Centre National de la Recherche Scientifique, and at Laboratoire de Virologies Experimentale, Institut Pasteur, all in Paris, France ("Preservation of graft-versus-infection after suicide gene therapy for prevention of graft-versus-host disease," Human Gene...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2000-12-28)
More Articles from Gene Therapy Weekly
- Gene Targeting
Study Demonstrates Feasibility of Correcting Mutant Genes in Hematopoietic Stem Cells - Hemophilia
Scientists Bypass Major Hurdle to Gene Therapy; Animal Studies Yield High Levels of Clotting Protein - Cystic Fibrosis
Anti-Inflammatory Protein Improves Gene Therapy Protocol - Immunology
Transgenic Expression of Receptor Enables Investigation of Primary T Cells - Myocardial Ischemia
Injecting Adeno-Associated Viral Vector into Myocardium Enables Gene Transfer, Angiogenesis - Cancer Gene Therapy
Data Support Development of Gene-Based Immunotherapies - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
